Literature DB >> 6150976

The in-vivo evaluation of an osmotic device (Osmet) using gamma scintigraphy.

S S Davis, J G Hardy, M J Taylor, A Stockwell, D R Whalley, C G Wilson.   

Abstract

The release of a radiolabelled marker from an orally administered osmotic pump device (Osmet) has been evaluated in-vivo in a group of 6 subjects, using the technique of gamma scintigraphy. The duration of residence of the pump in the stomach was greatly influenced by food intake. However, the release of the marker from the device was independent of food and position within the gastrointestinal tract. Furthermore, the material released from the osmotic pump was well distributed in the gastrointestinal tract. Good agreement between in-vitro and in-vivo release rates was obtained.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150976     DOI: 10.1111/j.2042-7158.1984.tb04862.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  11 in total

Review 1.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 3.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

4.  Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.

Authors:  P A Soons; A G de Boer; P van Brummelen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 5.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 6.  The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.

Authors:  J S Grundy; R T Foster
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

7.  Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.

Authors:  Jitendra R Amrutkar; Surendra G Gattani
Journal:  AAPS PharmSciTech       Date:  2009-05-21       Impact factor: 3.246

8.  Anionic carbohydrate-containing chitosan scaffolds for bone regeneration.

Authors:  Hyejin Park; Bogyu Choi; John Nguyen; Jiabing Fan; Sahar Shafi; Perry Klokkevold; Min Lee
Journal:  Carbohydr Polym       Date:  2013-05-21       Impact factor: 9.381

9.  Whole-bowel transit in patients with the irritable bowel syndrome.

Authors:  J G Hardy; E Wood; A G Clark; J R Reynolds
Journal:  Eur J Nucl Med       Date:  1986

10.  Preparation and gamma scintigraphic evaluation of colon specific pellets of ketoprofen prepared by powder layering technology.

Authors:  M Subhabrota; R Souvik; C Subhadeep
Journal:  Daru       Date:  2011       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.